Kyungran Gibson
Physician Assistant · Portsmouth, NHNPI 1649897372
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 287 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 287 payments — averaging $19.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$949
- Takeda Pharmaceuticals U.S.A., Inc.$710
- Gilead$433
- Phathom Pharmaceuticals, Inc.$333
- Sanofi$316
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,704100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 76 | $1,219 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 69 | $949 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $710 |
| Gilead | 15 | $433 |
| Phathom Pharmaceuticals, Inc. | 6 | $333 |
| Sanofi | 9 | $316 |
| Daiichi Sankyo Inc. | 16 | $274 |
| Ironwood Pharmaceuticals, Inc | 7 | $177 |
| Pfizer | 6 | $119 |
| Lilly USA, LLC | 4 | $99 |
| Intercept Pharmaceuticals, Inc. | 4 | $97 |
| Bristol Myers Squibb | 4 | $93 |
| Ardelyx, Inc. | 3 | $93 |
| Johnson & Johnson(2 entities) | 5 | $92 |
| QOL Medical, LLC | 3 | $80 |
| Aimmune Therapeutics, Inc. | 3 | $73 |
| Organon | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 3 | $60 |
| Madrigal Pharmaceuticals | 1 | $45 |
| E.r. Squibb & Sons, L.L.C. | 1 | $43 |
| Biodelivery Sciences International, Inc. | 2 | $38 |
| Merz Pharmaceuticals, LLC | 2 | $36 |
| Amgen | 2 | $34 |
| Vertos Medical, Inc. | 1 | $33 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Braintree Laboratories, Inc. | 1 | $22 |
| Redhill Biopharma Inc. | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Celltrion USA Inc. | 1 | $19 |
| Lucid Diagnostics Inc. | 1 | $18 |
| Bausch & Lomb Americas Inc. | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Merck | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Exact Sciences | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,715 in reported general payments places this provider in the 95th percentile of 782 physician assistant providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 15 | $50,409 |
| XifaxanRifaximin | 15 | $48,582 |
| LinzessLinaclotide | 41 | $36,526 |
| Mesalamine | 30 | $32,391 |
| Omeprazole | 324 | $4,793 |
| Budesonide DrBudesonide | 26 | $2,943 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 17 | $2,918 |
| Pantoprazole Sodium | 97 | $2,212 |
| Esomeprazole Magnesium | 34 | $1,101 |
| Dicyclomine Hcl | 47 | $1,071 |
| Ondansetron OdtOndansetron | 18 | $934 |
| Famotidine | 55 | $830 |
| Lansoprazole | 14 | $479 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 11 | $330 |
| Nortriptyline Hcl | 24 | $182 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $1,219 | $86,93556 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $949 | $48,58215 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $20 | $2,91817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 782 physician assistant providers in New Hampshire.
Other physician assistant in Portsmouth
- Evelyn SteinPortsmouth$26K
- Kelly RouleauPortsmouth$12K
- Jacob LareauPortsmouth$2K
- Angela DemienPortsmouth$2K
- Joseph ZucchiSalem$40K
- Lindsay OverkoConcord$29K
- Shari AshtonManchester$24K
- Jacqueline WattsStratham$22K
- Ryan StrasserStratham$17K
- Karima PerettiManchester$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.